DoW Bone Marrow Failure, Idea Development Award
This grant supports innovative research ideas from both established and early-career investigators to advance understanding and treatment of bone marrow failure, without requiring preliminary data.
Funder: Dept. of the Army -- USAMRAA
Due Dates: August 5, 2026: Pre-Application | November 4, 2026: Full Application | November 12, 2026: Application Verification
Funding Amounts: ~$4,000,000 total; up to $800,000 per award (direct + indirect), max 3 years, ~5 awards expected
Summary: Supports innovative, high-impact research to advance understanding and cures for bone marrow failure (BMF) diseases; open to both early-career and established investigators.
Key Information: Preliminary data not required; clinical trials are not allowed; application is a two-stage process (pre-application and invited full application).
Description
This opportunity from the Bone Marrow Failure Research Program (BMFRP) Idea Development Award (IDA) supports innovative, high-impact research aimed at advancing understanding and cures for inherited or acquired bone marrow failure (BMF) diseases. The program funds both Established Investigators (EIs) and Early-Career Investigators (ECIs), using distinct review criteria for each. The intent is to encourage bold, hypothesis-driven research that can generate interpretable results even in the absence of preliminary data. Clinical trials are not permitted, but correlative studies associated with clinical trials or clinical samples are allowed.
Projects must address at least one of the FY26 BMFRP focus areas:
- Finding effective BMF treatments and cures
- Understanding the causes and progression of BMF diseases
Eligible research includes studies on a range of BMF diseases (e.g., aplastic anemia, Fanconi anemia, myelodysplastic syndromes, etc.), but not those primarily focused on myeloproliferative neoplasms, leukemia, or other malignancies.
